Delivery Order SPE2DE21D0005-SPE2D625F6K0U
Award Date 5/6/25
Potential Completion Date 5/9/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, received a delivery order for APLIGRAF from the Defense Logistics Agency (DLA) Medical Supply Chain on October 15, 2025. This fixed-price contract with economic price adjustment carries a ceiling value of $2,479.90 and is scheduled for completion by October 20, 2025. The award was made without any set-aside designation, indicating Organogenesis competed as a standard commercial vendor. APLIGRAF is an advanced...
- Organogenesis Inc. has been awarded a delivery order valued at $1,239.95 for APLIGRAF, a regenerative medicine product, with an ultimate completion date of October 31, 2025. This fixed-price delivery order with economic price adjustment was issued on October 28, 2025, by the Defense Logistics Agency's Medical Supply Chain division to support federal healthcare operations. The work will be performed at Organogenesis's facility in Canton, Massachusetts. No set-aside designation was utilized for...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $1,239.95 for APLIGRAF, an advanced wound care and tissue regeneration product. The contract, awarded on May 30, 2025, with an ultimate completion date of June 4, 2025, utilizes fixed-price pricing with economic price adjustment terms. The award was made without a set-aside designation, indicating that Organogenesis competed as a standard commercial vendor. The...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $1,239.95 for APLIGRAF, an advanced wound care and tissue regeneration product. The contract was issued on October 14, 2025, with an ultimate completion date of October 17, 2025, and carries fixed-price pricing with economic price adjustment terms. No set-aside designation was utilized for this award. The contract is funded through the Defense Logistics Agency's...
- On May 12, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,239.95 to Organogenesis Inc. for APLIGRAF, an advanced regenerative medicine product used in wound care and tissue regeneration. The contract is classified as fixed price with economic price adjustment and carries an ultimate completion date of May 15, 2025. This delivery order was issued without set-aside designation, reflecting Organogenesis's status as a standard commercial vendor...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $1,239.95 by the Defense Logistics Agency's Medical Supply Chain division on October 28, 2025, with an ultimate completion date of October 31, 2025. The award covers APLIGRAF, an advanced skin substitute product used for wound care and tissue regeneration. This delivery order was issued under a fixed-price contract with economic price adjustment terms and did not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 fixed-price delivery order is for the supply of the APLIGRAF wound care product. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued at up...
- This $1,239.95 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Medical Supply Chain division of the Defense Logistics Agency. The order is for APLIGRAF, a wound care product, and has a completion date of March 20, 2024. Organogenesis previously held several large Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs and Defense Logistics Agency to supply surgical implants, wound care matrices, and other tissue...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,239.95 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, for the supply of APLIGRAF, a specialized wound care product. The contract has a fixed price with economic price adjustment pricing type and an ultimate completion date of December 27, 2024. This award is part of Organogenesis' larger federal contract vehicles, including a $25 million single-award Indefinite Delivery Contract...
- This is a $3,719.85 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The order is for the company's APLIGRAF advanced wound care product. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25 million single-award Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs (VA) for next-generation surgical...